Kraig Biocraft Laboratories reports recurring developments in recombinant spider silk technology, including production scale-up, new rearing capacity, cocoon output, and downstream reeling into usable silk fiber. The company’s technology is built around scientifically engineered silkworms that incorporate key spider silk proteins, with updates often tied to commercialization of materials for technical textiles, luxury wear, performance apparel, and other high-performance applications.
KBLB news also covers R&D execution, strain development, yield optimization, fiber performance, South East Asia production activity, and coordination with Prodigy Silk and related production networks.
Kraig Biocraft Laboratories (KBLB) delivered its first commercial spider silk yarn order to a sportswear brand for a confidential performance-apparel pilot. It also shipped requested samples to a textile innovator, announced October 26. August cocoon production exceeded June's record of nearly 2.5 metric tons by more than 30%.
Kraig applied for an expanded investment license for its Vietnamese subsidiary, Prodigy Silk, to support additional capacity and infrastructure. Its early-stage dietary-additive program aims to improve silk production. Project Atlas incorporated every planned transgene into living silkworm hosts; establishing stable breeding lines and evaluating more than 200 potential genetic combinations are next.
Kraig Biocraft Laboratories (KBLB) delivered its first commercial spider silk yarn order to a global sports brand for a paid pilot. Announced September 29, the shipment was custom processed for a confidential athletic apparel program. On October 26, Kraig announced a separate shipment of requested samples to a yarn-spinning specialist with aerospace development experience.
Kraig also launched a program to develop additional yarn constructions and material blends. Production included nearly 2.5 metric tons of cocoons from the May–June cycle, followed by an August increase exceeding 30% over that record. These figures measure cocoons, not finished silk or yarn. An October 5 update reported all three production centers operating on staggered schedules.
Kraig Biocraft Laboratories (KBLB) shipped its first commercial recombinant spider silk yarn order to a globally recognized sportswear brand. The delivery, announced September 29, supports a confidential performance-apparel pilot. On October 26, Kraig announced requested sample shipments to a textile innovator known for advanced yarn-spinning equipment.
August cocoon production exceeded June’s record of nearly 2.5 metric tons by more than 30%. Three rearing centers operate on staggered schedules. Kraig applied for an expanded investment license for Vietnamese subsidiary Prodigy Silk to support additional capacity and infrastructure. A dietary-additive testing program announced November 2 remains in its early stages; the company aims to improve protein output and fiber performance.
Kraig Biocraft Laboratories (KBLB) launched a dietary-additive research program targeting spider silk protein production in its genetically enhanced silkworms.
The program focuses on supplying nutritional building blocks for specific spider silk proteins, complementing the company's genetic engineering work. Kraig Labs believes the approach could improve silk output and quality. Research remains in its early stages, with candidate additives being evaluated for their effects on protein production and fiber performance. Chief Scientist Xiaoli Zhang reported positive initial signs. The program joins existing research in genetic engineering, new genetically modified silkworm development and production scale-up.
Kraig Biocraft Laboratories (KBLB) shipped recombinant spider-silk samples to an equipment developer with experience working on materials alongside aerospace manufacturers.
The recipient requested the samples and is known for advanced yarn-spinning equipment. Kraig also launched a program to develop yarn constructions and material blends, following September delivery of custom yarn to a performance sports brand. No specific aerospace application or contract has been disclosed.
In September 2026, Kraig completed its Project Atlas Gene Library, establishing every planned Atlas transgene in living commercial silkworm hosts. Its next phase focuses on stable breeding lines and evaluating more than 200 potential genetic configurations, targeting improved fiber properties.
Kraig Biocraft Laboratories (KBLB) has launched a performance-yarn development program and shipped recombinant spider silk samples to a materials innovator.
The recipient has experience collaborating with aerospace manufacturers. The program follows the company's first commercial spider silk yarn shipment in September to a performance sportswear brand, delivering a customer-specific product. Recombinant spider silk is produced by genetically engineered silkworms that make spider silk proteins.
Production reached nearly 2.5 metric tons of cocoons in a single June cycle, followed by another production record in August. In October, the company reported that all three production centers were operating as commercial deliveries began.
Kraig Biocraft Laboratories (KBLB) launched a performance yarn development program and shipped spider silk samples to a yarn technology firm. The program builds on a recent sale and shipment of custom yarn to a performance apparel customer. It will develop new yarn constructions and material blends for fabrics, apparel and other materials.
The sample recipient requested the shipment and has experience collaborating with tier-1 aerospace manufacturers on materials development. Kraig Labs expects the program to support multiple commercialization paths, potentially including collaborations with brands, mills and manufacturers, as well as its own apparel development.
Kraig Biocraft Laboratories (KBLB) will have COO Jon Rice present at the International Sericultural Commission Congress, held November 23–27, 2026. The event takes place in Chennai, India. His presentation will examine the commercial impact of genetic engineering on silk markets, including recombinant spider silk and the company's production model designed to use existing silk industry infrastructure.
Kraig Biocraft Laboratories (OTCQB: KBLB) shipped its first commercial spider silk yarn order to a performance sports brand on September 29, 2026. The custom yarn met the customer's specifications for a confidential pilot development program. On August 24, production exceeded the previous record by more than 30%.
The company completed integration of every planned Atlas transgene into living commercial silkworm hosts on September 24. Next steps involve establishing stable breeding lines and evaluating more than 200 potential genetic pairing configurations. On October 5, its September/October production cycle was underway at three centers on staggered schedules, concentrating on parental strains that supply hybrid eggs. On October 12, its Prodigy Silk subsidiary applied for an expanded investment license intended to support additional capacity and infrastructure.
Kraig Biocraft Laboratories (KBLB) filed for an expanded investment license for Prodigy Silk to support increased spider silk production capacity.
The company is seeking additional capital to expand capacity and infrastructure. It produced nearly 2.5 metric tons of spider silk cocoons in June 2026 and exceeded that record by more than 30% in August. Three rearing centers are fully operational, supported by expanded mulberry cultivation and a vertically integrated production system.
Kraig also shipped its first custom spider silk yarn for a performance sportswear application. The expansion still depends on investment approvals and funding; economically increasing output and converting early industrial interest into sustained commercial orders remain execution challenges.